isradipine has been researched along with Interstitial Cell Tumor in 1 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prentice, DE | 1 |
| Siegel, RA | 1 |
| Donatsch, P | 1 |
| Qureshi, S | 1 |
| Ettlin, RA | 1 |
1 other study available for isradipine and Interstitial Cell Tumor
| Article | Year |
|---|---|
Mesulergine induced Leydig cell tumours, a syndrome involving the pituitary-testicular axis of the rat.
Topics: Animals; Dihydropyridines; Ergolines; Isradipine; Leydig Cell Tumor; Male; Pituitary Hormones; Rats; | 1992 |